Diagnosis and Management of Polyendocrinopathy Syndromes

Endocrinology and Metabolism Clinics of North America

Volumn 38, Issue 2, 2009, Pages 419-436

  Owen, Catherine J ^a   Cheetham, Tim D ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

APS1; APS2; IPEX

Indexed keywords

AUTOANTIBODY; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 1; HORMONE; INSULIN; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22;

ADDISON DISEASE; ADRENAL INSUFFICIENCY; AUTOIMMUNE DISEASE; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 2; AUTOIMMUNE POLYGLANDULAR SYNDROME TYPE 3; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FOLLOW UP; GRAVES DISEASE; HASHIMOTO DISEASE; HORMONE SUBSTITUTION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; POLYENDOCRINOPATHY; POSTPARTUM THYROIDITIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THYROID DISEASE;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYENDOCRINOPATHIES, AUTOIMMUNE;

EID: 62749130573     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ecl.2009.01.007     Document Type: Review

References (66)

1. Neufeld M., Maclaren N.K., et al. Two types of auto-immune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 60 5 (1981) 355-362
2. Laureti S., Vecchi L., et al. Is the prevalence of Addison disease underestimated?. J Clin Endocrinol Metab 84 5 (1999) 1762
3. Falorni A., Laureti S., et al. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 31 2 (2002) 369-389
4. Betterle C., Dal Pra C., et al. Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23 3 (2002) 327-364
5. Betterle C., Volpato M., et al. Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 9 Suppl 1 (1996) 113-123
6. Betterle C., Lazzarotto F., et al. Autoimmune polyglandular syndrome type 2: the tip of an iceberg?. Clin Exp Immunol 137 2 (2004) 225-233
7. Murray J.S., Jayarajasingh R., et al. Deterioration of symptoms after start of thyroid hormone replacement. BMJ 323 7308 (2001) 332-333
8. Leslie R.D., Williams R., et al. Type 1 diabetes and latent autoimmune diabetes in adults: one end of the rainbow. J Clin Endocrinol Metab 91 5 (2006) 1654-1659
9. Schatz D.A., and Winter W.E. Autoimmune polyglandular syndrome II: clinical syndrome and treatment. Endocrinol Metab Clin North Am 31 2 (2002) 339-352
10. Belvisi L., Bombelli F., et al. Organ-specific autoimmunity in patients with premature ovarian failure. J Endocrinol Invest 16 11 (1993) 889-892
11. Betterle C., Volpato M., et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison disease. J Clin Endocrinol Metab 82 3 (1997) 932-938
12. Yamaguchi Y., Chikuba N., et al. Islet cell antibodies in patients with autoimmune thyroid disease. Diabetes 40 3 (1991) 319-322
13. Mandry R.C., Ortiz L.J., et al. Organ-specific autoantibodies in vitiligo patients and their relatives. Int J Dermatol 35 1 (1996) 18-21
14. Robles D.T., Fain P.R., et al. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 31 2 (2002) 353-368
15. Huang W., Connor E., et al. Although DR3-DQB1*0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1*0302 haplotype is implicated only in beta-cell autoimmunity. J Clin Endocrinol Metab 81 7 (1996) 2259-2263
16. Donner H., Braun J., et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto thyroiditis and Addison disease. J Clin Endocrinol Metab 82 12 (1997) 4130-4132
17. Yanagawa T., Hidaka Y., et al. CTLA-4 gene polymorphism associated with Graves disease in a Caucasian population. J Clin Endocrinol Metab 80 1 (1995) 41-45
18. Vaidya B., Pearce S., et al. Recent advances in the molecular genetics of congenital and acquired primary adrenocortical failure. Clin Endocrinol (Oxf) 53 4 (2000) 403-418
19. Nisticò L., Buzzetti R., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgium Diabetes Registry. Hum Mol Genet 5 7 (1996) 1075-1080
20. De Nanclares G.P., Martin-Pagola A., et al. No evidence of association of CTLA4 polymorphisms with Addison's disease. Autoimmunity 37 6-7 (2004) 453-456
21. Velaga M.R., Wilson V., et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease. J Clin Endocrinol Metab 89 11 (2004) 5862-5865
22. Skinningsrud B., Husebye E.S., et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 16 8 (2008) 977-982
23. Roycroft M., Fichna M., et al. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22 gene) predisposes to autoimmune Addison's disease. Clin Endocrinol (Oxf) (Aug 15, 2008) 10.1111/j.1365-2265.2008.03380.x [Epub ahead of print]
24. Kamradt T., and Mitchison N.A. Tolerance and autoimmunity. N Engl J Med 344 9 (2001) 655-664
25. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199 9 (2004) 1285-1291
26. Vendrame F., Segni M., et al. Impaired caspase-3 expression by peripheral T cells in chronic autoimmune thyroiditis and in autoimmune polyendocrine syndrome-2. J Clin Endocrinol Metab 91 12 (2006) 5064-5068
27. Betterle C., Volpato M., et al. Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 84 2 (1999) 618-622
28. Vanderpump M.P., Tunbridge W.M., et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Wickham Survey. Clin Endocrinol (Oxf) 43 1 (1995) 55-68
29. Vandewalle C.L., Falorni A., et al. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in insulin-dependent diabetes mellitus with clinical onset between age 20 and 40 years. The Belgian Diabetes Registry. J Clin Endocrinol Metab 80 3 (1995) 846-851
30. Bergthorsdottir R., Leonsson-Zachrisson M., et al. Premature mortality in patients with Addison's disease: a population based study. J Clin Endocrinol Metab 91 12 (2006) 4849-4853
31. Lovas K., and Husebye E.S. High prevalence and increasing incidence of Addison disease in western Norway. Clin Endocrinol (Oxf) 56 6 (2002) 787-791
32. Ahonen P., Myllärniemi S., et al. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322 26 (1990) 1829-1836
33. Zlotogora J., and Shapiro M.S. Polyglandular autoimmune syndrome type I among Iranian Jews. J Med Genet 29 11 (1992) 824-826
34. Betterle C., Greggio N.A., et al. Clinical review 93: autoimmune polyglandular syndrome type I. J Clin Endocrinol Metab 83 4 (1998) 1049-1055
35. Myhre A.G., Halonen M., et al. Autoimmune polyendocrine syndrome type I (APS1) in Norway. Clin Endocrinol (Oxf) 54 2 (2001) 211-217
36. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 31 2 (2002) 295-320
37. Pearce S.H., and Cheetham T.D. Autoimmune polyendocrinopathy syndrome type I: treat with kid gloves. Clin Endocrinol (Oxf) 54 4 (2001) 433-435
38. Rosatelli M.C., Meloni A., et al. A common mutation in Sardinian autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. Hum Genet 103 4 (1998) 428-434
39. Gass J.D. The syndrome of keratoconjunctivitis, superficial moniliasis idiopathic hypoparathyroidism and Addison disease. Am J Ophthalmol 54 (1962) 660-674
40. Gylling M., Kääriäinen E., et al. The hypoparathyroidism of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy protective effect of male sex. J Clin Endocrinol Metab 88 10 (2003) 4602-4608
41. Perheentupa J. Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Clin Endocrinol Metab 91 8 (2006) 2843-2850
42. Sotsiou F., Bottazzo G.F., et al. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 39 1 (1980) 97-111
43. Bereket A., Lowenheim M., et al. Intestinal lymphangiectasia in a patient with autoimmune polyglandular disease type I and steatorrhea. J Clin Endocrinol Metab 80 3 (1995) 933-935
44. Högenauer C., Meyer R.L., et al. Malabsorption due to cholecystokinin deficiency in a patient with autoimmune polyglandular syndrome type 1. N Engl J Med 344 4 (2001) 270-274
45. Smith D., Stringer M.D., et al. Orthoptic liver transplantation for acute liver failure secondary to autoimmune hepatitis in a child with autoimmune polyglandular syndrome type 1. Pediatr Transplant 6 2 (2002) 166-170
46. Nagamine K., Peterson P., et al. Positional cloning of the APECED gene. Nature Genet 17 4 (1997) 393-398
47. The Finnish-German APECED Consortium. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. Nature Genet 17 4 (1997) 399-403
48. Liston A., Lesage S., et al. AIRE regulates negative selection of organ-specific T cells. Nat Immunol 4 4 (2003) 350-354
49. Mathis D., and Benoist C. A decade of AIRE. Nat Rev Immunol 7 8 (2007) 645-650
50. Pearce S.H., Cheetham T., et al. A common and recurrent 13-bp deletion in the autoimmune regulator gene in British kindreds with autoimmune polyendocrinopathy type I. Am J Hum Genet 63 6 (1998) 1675-1684
51. Wolff A.S., Erichsen M.M., et al. Autoimmune polyendocrinopathy syndrome type 1 in Norway: phenotypic variation, autoantibodies, and novel mutations in the autoimmune regulator gene. J Clin Endocrinol Metab 92 2 (2007) 595-603
52. Halonen M., Eskelin P., et al. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab 87 6 (2002) 2568-2574
53. Adamson K.A., Cheetham T.D., et al. The role of the IDDM2 locus in the susceptibility of UK APS1 subjects to type 1 diabetes mellitus. Int J Immunogenet 34 1 (2007) 17-21
54. Meager A., Visvalingam K., et al. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 3 7 (2006) 1152-1164
55. Söderbergh A., Myhre A.G., et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 89 2 (2004) 557-562
56. Li Y., Song Y.H., et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97 4 (1996) 910-914
57. Gavalas N.G., Kemp E.H., et al. The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1. J Clin Endocrinol Metab 92 6 (2007) 2107-2114
58. Alimohammadi M., Björklund P., et al. Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358 10 (2008) 1018-1028
59. Tuomi T., Björses P., et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 81 4 (1996) 1488-1494
60. Obermayer-Straub P., Perheentupa J., et al. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Gastroenterology 121 3 (2001) 668-677
61. Wildin R.S., Smyk-Pearson S., et al. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet 39 8 (2002) 537-545
62. Powell B.R., Buist N.R., et al. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100 5 (1982) 731-737
63. Owen C.J., Jennings C.E., et al. Mutational analysis of the FOXP3 gene and evidence for genetic heterogeneity in the immunodysregulation, polyendocrinopathy, enteropathy syndrome. J Clin Endocrinol Metab 88 12 (2003) 6034-6039
64. + regulatory T cells. Nat Immunol 4 4 (2003) 330-336
65. Gavin M.A., Torgerson T.R., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103 17 (2006) 6659-6664
66. Caudy A.A., Reddy S.T., et al. CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome, and defective IL-10 expression from CD4 lymphocytes. J Allergy Clin Immunol 119 2 (2007) 482-487